Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (138)	12/26/1997 8:17:00 PM
From: Valueman	Respond to of 296

Swiss Helvetia Fund is a closed-end fund that trades on the NYSE under symbol SWZ.

To: Sonki who wrote (138)	12/27/1997 4:20:00 AM
From: Ted Scheidegger	Read Replies (2) \| Respond to of 296

The fund is the Swiss Helvetia Fund (SWZ) traded on NYSE. It did indeed have 22.2% of NAV invested in Novartis on Sept 30, 1997. The position may have changed in the mean time. A call to the fund manager would clarify this. I am not aware of a swiss index fund for US investors. However, the NAV of SWZ has closely tracked the SMI index in the past. Keep in mind however, that the fund has historically most often traded at a discount to NAV. This can lead to attractive entry points into the swiss market (IMO when discount >20% and SMI >10% off previous high) for investors with a long term perspective. Ted